Sensei Biotherapeutics, Inc. (SNSE)

NASDAQ: SNSE · IEX Real-Time Price · USD

1.000

+0.008 (0.85%)

At close: Apr 25, 2024, 4:00 PM

1.040

+0.040 (3.99%)

After-hours: Apr 25, 2024, 4:00 PM EDT

Sensei Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	18.77	19.81	15.82	7.53	4.09	4.51
Research & Development	18.3	30.38	21.66	11.19	8.35	8.23
Other Operating Expenses	0	0	0	0.74	0	0
Operating Expenses	37.06	50.19	37.48	19.45	12.44	12.74
Operating Income	-37.06	-50.19	-37.48	-19.45	-12.44	-12.74
Interest Expense / Income	0.14	0.22	0.67	1.69	2.26	0.33
Other Expense / Income	-3.11	-1.82	-1.36	-1.04	2.05	-0.03
Pretax Income	-34.1	-48.59	-36.79	-20.1	-16.74	-13.04
Net Income	-34.1	-48.59	-36.79	-20.1	-16.74	-13.04
Preferred Dividends	0	0	0	0.1	3.8	3.8
Net Income Common	-34.1	-48.59	-36.79	-20.2	-20.54	-16.84
Shares Outstanding (Basic)	28	31	28	2	0	18
Shares Outstanding (Diluted)	28	31	28	2	0	18
Shares Change	-8.96%	10.80%	1618.88%	338.85%	-97.92%	-
EPS (Basic)	-1.22	-1.58	-1.33	-12.53	-55.92	-0.96
EPS (Diluted)	-1.22	-1.58	-1.33	-12.53	-55.92	-0.96
Free Cash Flow	-32.04	-39.33	-31.97	-18.91	-8.62	-10.34
Free Cash Flow Per Share	-1.15	-1.28	-1.15	-11.73	-23.48	-0.59
EBITDA	-31.25	-45.83	-35.44	-18.2	-14.41	-12.67
Depreciation & Amortization	2.71	2.54	0.69	0.21	0.07	0.04
EBIT	-33.96	-48.37	-36.12	-18.41	-14.48	-12.71

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).